semaglutide microneedle patch Efficient transdermal drug delivery via a lance-microneedle delivery system with thumb force application A team, including researchers from

Pfizer halted development of its oral GLP-1 danuglipron in 2025 after a trial participant developed liver injury, reflecting safety concerns that require ongoing monitoring with real-world data

Without GLP-1 stimulation, patients may return to old eating habits

Officials also proposed converting one engine from permanent staffing to cheaper overtime

USE Apply 1 ml directly to the tongue with each of the 2 main meals or add to a little water and drink before or after a main meal

Sanyal, MD, Professor of Medicine, Physiology, and Molecular Pathology and Interim-Chair of Gastroenterology, Hepatology, and Nutrition, Virginia Commonwealth University